The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

57.94 0.54 +0.94%
Market cap
$10.9B
P/E
19.8×
Fwd P/E
28.7×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a

The Cooper Companies, Inc. (COO) Total debt

Alert me on Total debt

The Cooper Companies, Inc.'s total debt at the end of fiscal 2025 was $2.5B, unchanged from fiscal 2024. At the end of the quarter to 31 July 2026 it was $2.5B. Over the past ten years it has ranged from $1.2B (fiscal 2017) to $2.8B (fiscal 2022); the current reading is higher than 73% of that period. The Cooper Companies, Inc. ranks 9th of 54 Medical Instruments & Supplies companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $2.5B (3.03%)
FY2024 $2.6B 0.56%
FY2023 $2.6B (7.03%)
FY2022 $2.8B 86.59%
FY2021 $1.5B (17.41%)
FY2020 $1.8B (1.81%)
FY2019 $1.8B (9.71%)
FY2018 $2.0B 72.49%
FY2017 $1.2B (12.07%)
FY2016 $1.3B (1.15%)

Quarterly newest first

Period Total debt Change
Jul 2026 $2.5B 3.41%
Apr 2026 $2.5B (1.58%)
Jan 2026 $2.5B (0.22%)
Oct 2025 $2.5B 1.09%
43 more quarters

Against its own ten years

Low $1.2B High $2.8B
Ten-year median $1.8B
Current reading's percentile 73

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on COO